
Will Analyst Optimism on Salomon and Arc'teryx Sales Shift Amer Sports' (AS) Investment Narrative?

Amer Sports is experiencing positive analyst sentiment, anticipating higher revenues and earnings for the June 2025 quarter, driven by strong sales from Salomon and Arc'teryx. UBS has updated its earnings guidance, reflecting the company's ability to navigate tariff challenges. Analysts project a revenue growth of 15% to 17% for 2025, with a long-term outlook of $8.2 billion in revenue by 2028. However, the company's reliance on a few key brands poses risks. Fair value estimates for Amer Sports range from $14.38 to $41.73 per share, highlighting diverse perspectives on its future performance.
- Amer Sports recently attracted upbeat analyst sentiment as it is expected to report higher revenues and potentially outperform earnings estimates for the June 2025 quarter, supported by strong sales from its Salomon and Arc'teryx brands.
- UBS noted the company updated its earnings guidance, indicating an ability to manage tariff challenges and continue its sales momentum through robust brand performance.
- We'll now explore how analysts' positive earnings outlook, driven by accelerating brand strength, could influence Amer Sports' investment narrative.
These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
Amer Sports Investment Narrative Recap
To believe in Amer Sports as a shareholder, one must have confidence in the enduring strength of its flagship brands, particularly Salomon and Arc'teryx, and in the execution of aggressive growth plans across Asia-Pacific and direct-to-consumer channels. The latest analyst optimism surrounding earnings for the June 2025 quarter could bolster short-term sentiment, though it does not fundamentally alter the primary catalyst of sustained premium brand momentum or offset the biggest near-term risk: over-reliance on these same brands for revenue and margin expansion.
Among recent announcements, Amer Sports' May update to corporate guidance stands out. Lifting full-year 2025 revenue growth expectations to 15% to 17% and confirming stable EPS guidance directly align with analysts' bullish outlook, reinforcing the thesis that continued sales strength from core brands and resilience through tariff headwinds remain central to investor confidence.
However, even as brand power fuels this upbeat outlook, investors should not overlook how concentrated exposure to just a few product lines means any missteps could quickly shift the story...
Read the full narrative on Amer Sports (it's free!)
Amer Sports' outlook anticipates $8.2 billion in revenue and $749.9 million in earnings by 2028. This implies a 14.4% annual revenue growth rate and an earnings increase of $547.8 million from current earnings of $202.1 million.
Uncover how Amer Sports' forecasts yield a $41.73 fair value, a 11% upside to its current price.
Exploring Other Perspectives
Four Simply Wall St Community analysts estimate fair value between US$14.38 and US$41.73 per share. With heavy reliance on key brands as a major risk, these diverse views remind you to consider multiple outcomes for future performance.
Explore 4 other fair value estimates on Amer Sports - why the stock might be worth less than half the current price!
Build Your Own Amer Sports Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Amer Sports research is our analysis highlighting 2 key rewards that could impact your investment decision.
- Our free Amer Sports research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amer Sports' overall financial health at a glance.
No Opportunity In Amer Sports?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
